Navigation Links
Invitrogen boosts drug development capability

Madison, Wis. - A California-based life sciences company with 120 Madison employees is bolstering its research toolbox to handle the most studied class of proteins in today's drug development market.

The new capability will be made possible by Invitrogen Corp.'s recent acquisition of Sentigen Holding Corp., which will be integrated with Invi......

Full article >>> cells that allow researchers to view cells in a state in which they do not divide.

The acquisition

The deal will allow Carlsbad-based Invitrogen to acquire Phillipsburg, N.J.-based Sentigen's two subsidiaries, Sentigen Biosciences, Inc. and Cell and Molecular Technologies, Inc., subject to approv......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 09/05/06


Related biology technology :

1. Prodesse joins forces with Invitrogen
2. Invitrogen to buy Norwegian biotech with operations in Brown Deer
3. Portal to e-records boosts care at Childrens Hospital
4. Federal grant boosts Medical College research
5. Third Wave boosts numbers in latest report
6. Small Tree boosts bandwidth for Apple G4 and G5 servers
7. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
8. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
9. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
10. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
11. The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2017)... CA (PRWEB) , ... May 19, 2017 , ... ... annual meeting and educational conference of the American Association of Bioanalysts (AAB) and ... Galleria Hotel in Houston. The conference reinforces AAB’s commitment to excellence in clinical ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... ... QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and who ... Jersey and Delaware, are encouraged to submit proposals. QED, now in its tenth ...
(Date:5/18/2017)... ... ... Clinical Supplies Management (“CSM”), a Great Point Partners II (“GPP”) portfolio company, ... has doubled in size over the past six months with the acquisition of businesses ... joins CSM as Chief Financial Officer. Roger has over 25 years of experience ...
(Date:5/18/2017)... (PRWEB) , ... May 17, 2017 , ... ... specializing in medical device compliance and commercialization, has just released version 9.0 of ... work into this latest version of Cockpit,” says David Cronin, CEO of Cognition. ...
Breaking Biology Technology:
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):